Medical Care
Global Precision Cancer Diagnostic Solutions Market Research Report 2025
- May 05, 25
- ID: 227111
- Pages: 89
- Figures: 89
- Views: 40
The global market for Precision Cancer Diagnostic Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Diagnostic Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Diagnostic Solutions.
The Precision Cancer Diagnostic Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Diagnostic Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Diagnostic Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
Thermo Fisher Scientific
Abbott Laboratories
BD
Siemens Healthineers
PHC Holdings
Agilent
Sakura Finetek
Epredia
bioMeriux
MDx Health
DiaSorin
Segment by Type
Hardware
Software and Services
Segment by Application
Hospital & Diagnostic Centers
Laboratories & Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Diagnostic Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Diagnostic Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Diagnostic Solutions.
The Precision Cancer Diagnostic Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Diagnostic Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Diagnostic Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
Thermo Fisher Scientific
Abbott Laboratories
BD
Siemens Healthineers
PHC Holdings
Agilent
Sakura Finetek
Epredia
bioMeriux
MDx Health
DiaSorin
Segment by Type
Hardware
Software and Services
Segment by Application
Hospital & Diagnostic Centers
Laboratories & Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Diagnostic Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software and Services
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital & Diagnostic Centers
1.3.3 Laboratories & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Solutions Market Perspective (2020-2031)
2.2 Global Precision Cancer Diagnostic Solutions Growth Trends by Region
2.2.1 Global Precision Cancer Diagnostic Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Diagnostic Solutions Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Diagnostic Solutions Market Dynamics
2.3.1 Precision Cancer Diagnostic Solutions Industry Trends
2.3.2 Precision Cancer Diagnostic Solutions Market Drivers
2.3.3 Precision Cancer Diagnostic Solutions Market Challenges
2.3.4 Precision Cancer Diagnostic Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue
3.1.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Diagnostic Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Diagnostic Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Diagnostic Solutions Revenue
3.4 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Solutions Revenue in 2024
3.5 Global Key Players of Precision Cancer Diagnostic Solutions Head office and Area Served
3.6 Global Key Players of Precision Cancer Diagnostic Solutions, Product and Application
3.7 Global Key Players of Precision Cancer Diagnostic Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Solutions Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Diagnostic Solutions Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Diagnostic Solutions Market Size (2020-2031)
6.2 North America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
6.4 North America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Solutions Market Size (2020-2031)
7.2 Europe Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Diagnostic Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Diagnostic Solutions Market Size (2020-2031)
9.2 Latin America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips Healthcare
11.1.1 Philips Healthcare Company Details
11.1.2 Philips Healthcare Business Overview
11.1.3 Philips Healthcare Precision Cancer Diagnostic Solutions Introduction
11.1.4 Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.1.5 Philips Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Introduction
11.2.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Precision Cancer Diagnostic Solutions Introduction
11.3.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Precision Cancer Diagnostic Solutions Introduction
11.4.4 BD Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.4.5 BD Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Details
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Precision Cancer Diagnostic Solutions Introduction
11.5.4 Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.5.5 Siemens Healthineers Recent Development
11.6 PHC Holdings
11.6.1 PHC Holdings Company Details
11.6.2 PHC Holdings Business Overview
11.6.3 PHC Holdings Precision Cancer Diagnostic Solutions Introduction
11.6.4 PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.6.5 PHC Holdings Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent Precision Cancer Diagnostic Solutions Introduction
11.7.4 Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.7.5 Agilent Recent Development
11.8 Sakura Finetek
11.8.1 Sakura Finetek Company Details
11.8.2 Sakura Finetek Business Overview
11.8.3 Sakura Finetek Precision Cancer Diagnostic Solutions Introduction
11.8.4 Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.8.5 Sakura Finetek Recent Development
11.9 Epredia
11.9.1 Epredia Company Details
11.9.2 Epredia Business Overview
11.9.3 Epredia Precision Cancer Diagnostic Solutions Introduction
11.9.4 Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.9.5 Epredia Recent Development
11.10 bioMeriux
11.10.1 bioMeriux Company Details
11.10.2 bioMeriux Business Overview
11.10.3 bioMeriux Precision Cancer Diagnostic Solutions Introduction
11.10.4 bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.10.5 bioMeriux Recent Development
11.11 MDx Health
11.11.1 MDx Health Company Details
11.11.2 MDx Health Business Overview
11.11.3 MDx Health Precision Cancer Diagnostic Solutions Introduction
11.11.4 MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.11.5 MDx Health Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Details
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Precision Cancer Diagnostic Solutions Introduction
11.12.4 DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.12.5 DiaSorin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software and Services
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital & Diagnostic Centers
1.3.3 Laboratories & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Solutions Market Perspective (2020-2031)
2.2 Global Precision Cancer Diagnostic Solutions Growth Trends by Region
2.2.1 Global Precision Cancer Diagnostic Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Diagnostic Solutions Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Diagnostic Solutions Market Dynamics
2.3.1 Precision Cancer Diagnostic Solutions Industry Trends
2.3.2 Precision Cancer Diagnostic Solutions Market Drivers
2.3.3 Precision Cancer Diagnostic Solutions Market Challenges
2.3.4 Precision Cancer Diagnostic Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue
3.1.1 Global Top Precision Cancer Diagnostic Solutions Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Diagnostic Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Diagnostic Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Diagnostic Solutions Revenue
3.4 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Solutions Revenue in 2024
3.5 Global Key Players of Precision Cancer Diagnostic Solutions Head office and Area Served
3.6 Global Key Players of Precision Cancer Diagnostic Solutions, Product and Application
3.7 Global Key Players of Precision Cancer Diagnostic Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Solutions Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Diagnostic Solutions Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Solutions Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Diagnostic Solutions Market Size (2020-2031)
6.2 North America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
6.4 North America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Solutions Market Size (2020-2031)
7.2 Europe Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Diagnostic Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Diagnostic Solutions Market Size (2020-2031)
9.2 Latin America Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Diagnostic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips Healthcare
11.1.1 Philips Healthcare Company Details
11.1.2 Philips Healthcare Business Overview
11.1.3 Philips Healthcare Precision Cancer Diagnostic Solutions Introduction
11.1.4 Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.1.5 Philips Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Introduction
11.2.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Precision Cancer Diagnostic Solutions Introduction
11.3.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Precision Cancer Diagnostic Solutions Introduction
11.4.4 BD Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.4.5 BD Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Details
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Precision Cancer Diagnostic Solutions Introduction
11.5.4 Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.5.5 Siemens Healthineers Recent Development
11.6 PHC Holdings
11.6.1 PHC Holdings Company Details
11.6.2 PHC Holdings Business Overview
11.6.3 PHC Holdings Precision Cancer Diagnostic Solutions Introduction
11.6.4 PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.6.5 PHC Holdings Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent Precision Cancer Diagnostic Solutions Introduction
11.7.4 Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.7.5 Agilent Recent Development
11.8 Sakura Finetek
11.8.1 Sakura Finetek Company Details
11.8.2 Sakura Finetek Business Overview
11.8.3 Sakura Finetek Precision Cancer Diagnostic Solutions Introduction
11.8.4 Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.8.5 Sakura Finetek Recent Development
11.9 Epredia
11.9.1 Epredia Company Details
11.9.2 Epredia Business Overview
11.9.3 Epredia Precision Cancer Diagnostic Solutions Introduction
11.9.4 Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.9.5 Epredia Recent Development
11.10 bioMeriux
11.10.1 bioMeriux Company Details
11.10.2 bioMeriux Business Overview
11.10.3 bioMeriux Precision Cancer Diagnostic Solutions Introduction
11.10.4 bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.10.5 bioMeriux Recent Development
11.11 MDx Health
11.11.1 MDx Health Company Details
11.11.2 MDx Health Business Overview
11.11.3 MDx Health Precision Cancer Diagnostic Solutions Introduction
11.11.4 MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.11.5 MDx Health Recent Development
11.12 DiaSorin
11.12.1 DiaSorin Company Details
11.12.2 DiaSorin Business Overview
11.12.3 DiaSorin Precision Cancer Diagnostic Solutions Introduction
11.12.4 DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025)
11.12.5 DiaSorin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hardware
Table 3. Key Players of Software and Services
Table 4. Global Precision Cancer Diagnostic Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Precision Cancer Diagnostic Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Precision Cancer Diagnostic Solutions Market Share by Region (2020-2025)
Table 8. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Precision Cancer Diagnostic Solutions Market Share by Region (2026-2031)
Table 10. Precision Cancer Diagnostic Solutions Market Trends
Table 11. Precision Cancer Diagnostic Solutions Market Drivers
Table 12. Precision Cancer Diagnostic Solutions Market Challenges
Table 13. Precision Cancer Diagnostic Solutions Market Restraints
Table 14. Global Precision Cancer Diagnostic Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Precision Cancer Diagnostic Solutions Market Share by Players (2020-2025)
Table 16. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2024)
Table 17. Ranking of Global Top Precision Cancer Diagnostic Solutions Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Precision Cancer Diagnostic Solutions, Headquarters and Area Served
Table 20. Global Key Players of Precision Cancer Diagnostic Solutions, Product and Application
Table 21. Global Key Players of Precision Cancer Diagnostic Solutions, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Cancer Diagnostic Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2020-2025)
Table 25. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2026-2031)
Table 27. Global Precision Cancer Diagnostic Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2020-2025)
Table 29. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2026-2031)
Table 31. North America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Philips Healthcare Company Details
Table 47. Philips Healthcare Business Overview
Table 48. Philips Healthcare Precision Cancer Diagnostic Solutions Product
Table 49. Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 50. Philips Healthcare Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Product
Table 54. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Abbott Laboratories Company Details
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Precision Cancer Diagnostic Solutions Product
Table 59. Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. BD Company Details
Table 62. BD Business Overview
Table 63. BD Precision Cancer Diagnostic Solutions Product
Table 64. BD Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 65. BD Recent Development
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Precision Cancer Diagnostic Solutions Product
Table 69. Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. PHC Holdings Company Details
Table 72. PHC Holdings Business Overview
Table 73. PHC Holdings Precision Cancer Diagnostic Solutions Product
Table 74. PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 75. PHC Holdings Recent Development
Table 76. Agilent Company Details
Table 77. Agilent Business Overview
Table 78. Agilent Precision Cancer Diagnostic Solutions Product
Table 79. Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 80. Agilent Recent Development
Table 81. Sakura Finetek Company Details
Table 82. Sakura Finetek Business Overview
Table 83. Sakura Finetek Precision Cancer Diagnostic Solutions Product
Table 84. Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 85. Sakura Finetek Recent Development
Table 86. Epredia Company Details
Table 87. Epredia Business Overview
Table 88. Epredia Precision Cancer Diagnostic Solutions Product
Table 89. Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 90. Epredia Recent Development
Table 91. bioMeriux Company Details
Table 92. bioMeriux Business Overview
Table 93. bioMeriux Precision Cancer Diagnostic Solutions Product
Table 94. bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 95. bioMeriux Recent Development
Table 96. MDx Health Company Details
Table 97. MDx Health Business Overview
Table 98. MDx Health Precision Cancer Diagnostic Solutions Product
Table 99. MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 100. MDx Health Recent Development
Table 101. DiaSorin Company Details
Table 102. DiaSorin Business Overview
Table 103. DiaSorin Precision Cancer Diagnostic Solutions Product
Table 104. DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 105. DiaSorin Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Precision Cancer Diagnostic Solutions Picture
Figure 2. Global Precision Cancer Diagnostic Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Cancer Diagnostic Solutions Market Share by Type: 2024 VS 2031
Figure 4. Hardware Features
Figure 5. Software and Services Features
Figure 6. Global Precision Cancer Diagnostic Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Precision Cancer Diagnostic Solutions Market Share by Application: 2024 VS 2031
Figure 8. Hospital & Diagnostic Centers Case Studies
Figure 9. Laboratories & Research Institutes Case Studies
Figure 10. Precision Cancer Diagnostic Solutions Report Years Considered
Figure 11. Global Precision Cancer Diagnostic Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Precision Cancer Diagnostic Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Precision Cancer Diagnostic Solutions Market Share by Region: 2024 VS 2031
Figure 14. Global Precision Cancer Diagnostic Solutions Market Share by Players in 2024
Figure 15. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Solutions Revenue in 2024
Figure 17. North America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 19. United States Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 23. Germany Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Precision Cancer Diagnostic Solutions Market Share by Region (2020-2031)
Figure 31. China Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 39. Mexico Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 43. Turkey Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Philips Healthcare Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 48. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 49. BD Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 50. Siemens Healthineers Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 51. PHC Holdings Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 52. Agilent Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 53. Sakura Finetek Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 54. Epredia Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 55. bioMeriux Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 56. MDx Health Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 57. DiaSorin Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Precision Cancer Diagnostic Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hardware
Table 3. Key Players of Software and Services
Table 4. Global Precision Cancer Diagnostic Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Precision Cancer Diagnostic Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Precision Cancer Diagnostic Solutions Market Share by Region (2020-2025)
Table 8. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Precision Cancer Diagnostic Solutions Market Share by Region (2026-2031)
Table 10. Precision Cancer Diagnostic Solutions Market Trends
Table 11. Precision Cancer Diagnostic Solutions Market Drivers
Table 12. Precision Cancer Diagnostic Solutions Market Challenges
Table 13. Precision Cancer Diagnostic Solutions Market Restraints
Table 14. Global Precision Cancer Diagnostic Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Precision Cancer Diagnostic Solutions Market Share by Players (2020-2025)
Table 16. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2024)
Table 17. Ranking of Global Top Precision Cancer Diagnostic Solutions Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Precision Cancer Diagnostic Solutions, Headquarters and Area Served
Table 20. Global Key Players of Precision Cancer Diagnostic Solutions, Product and Application
Table 21. Global Key Players of Precision Cancer Diagnostic Solutions, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Cancer Diagnostic Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2020-2025)
Table 25. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Type (2026-2031)
Table 27. Global Precision Cancer Diagnostic Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2020-2025)
Table 29. Global Precision Cancer Diagnostic Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Precision Cancer Diagnostic Solutions Revenue Market Share by Application (2026-2031)
Table 31. North America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Philips Healthcare Company Details
Table 47. Philips Healthcare Business Overview
Table 48. Philips Healthcare Precision Cancer Diagnostic Solutions Product
Table 49. Philips Healthcare Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 50. Philips Healthcare Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Precision Cancer Diagnostic Solutions Product
Table 54. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Abbott Laboratories Company Details
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Precision Cancer Diagnostic Solutions Product
Table 59. Abbott Laboratories Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 60. Abbott Laboratories Recent Development
Table 61. BD Company Details
Table 62. BD Business Overview
Table 63. BD Precision Cancer Diagnostic Solutions Product
Table 64. BD Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 65. BD Recent Development
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Precision Cancer Diagnostic Solutions Product
Table 69. Siemens Healthineers Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. PHC Holdings Company Details
Table 72. PHC Holdings Business Overview
Table 73. PHC Holdings Precision Cancer Diagnostic Solutions Product
Table 74. PHC Holdings Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 75. PHC Holdings Recent Development
Table 76. Agilent Company Details
Table 77. Agilent Business Overview
Table 78. Agilent Precision Cancer Diagnostic Solutions Product
Table 79. Agilent Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 80. Agilent Recent Development
Table 81. Sakura Finetek Company Details
Table 82. Sakura Finetek Business Overview
Table 83. Sakura Finetek Precision Cancer Diagnostic Solutions Product
Table 84. Sakura Finetek Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 85. Sakura Finetek Recent Development
Table 86. Epredia Company Details
Table 87. Epredia Business Overview
Table 88. Epredia Precision Cancer Diagnostic Solutions Product
Table 89. Epredia Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 90. Epredia Recent Development
Table 91. bioMeriux Company Details
Table 92. bioMeriux Business Overview
Table 93. bioMeriux Precision Cancer Diagnostic Solutions Product
Table 94. bioMeriux Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 95. bioMeriux Recent Development
Table 96. MDx Health Company Details
Table 97. MDx Health Business Overview
Table 98. MDx Health Precision Cancer Diagnostic Solutions Product
Table 99. MDx Health Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 100. MDx Health Recent Development
Table 101. DiaSorin Company Details
Table 102. DiaSorin Business Overview
Table 103. DiaSorin Precision Cancer Diagnostic Solutions Product
Table 104. DiaSorin Revenue in Precision Cancer Diagnostic Solutions Business (2020-2025) & (US$ Million)
Table 105. DiaSorin Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Precision Cancer Diagnostic Solutions Picture
Figure 2. Global Precision Cancer Diagnostic Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Cancer Diagnostic Solutions Market Share by Type: 2024 VS 2031
Figure 4. Hardware Features
Figure 5. Software and Services Features
Figure 6. Global Precision Cancer Diagnostic Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Precision Cancer Diagnostic Solutions Market Share by Application: 2024 VS 2031
Figure 8. Hospital & Diagnostic Centers Case Studies
Figure 9. Laboratories & Research Institutes Case Studies
Figure 10. Precision Cancer Diagnostic Solutions Report Years Considered
Figure 11. Global Precision Cancer Diagnostic Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Precision Cancer Diagnostic Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Precision Cancer Diagnostic Solutions Market Share by Region: 2024 VS 2031
Figure 14. Global Precision Cancer Diagnostic Solutions Market Share by Players in 2024
Figure 15. Global Top Precision Cancer Diagnostic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Solutions as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Solutions Revenue in 2024
Figure 17. North America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 19. United States Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 23. Germany Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Precision Cancer Diagnostic Solutions Market Share by Region (2020-2031)
Figure 31. China Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 39. Mexico Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Precision Cancer Diagnostic Solutions Market Share by Country (2020-2031)
Figure 43. Turkey Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Precision Cancer Diagnostic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Philips Healthcare Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 48. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 49. BD Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 50. Siemens Healthineers Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 51. PHC Holdings Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 52. Agilent Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 53. Sakura Finetek Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 54. Epredia Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 55. bioMeriux Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 56. MDx Health Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 57. DiaSorin Revenue Growth Rate in Precision Cancer Diagnostic Solutions Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232